Our technology platform:
-
L2L: Leap-to-Lead™ Overview
-
CFL: A proprietary next generation 3D fragment library
-
Syntheverse™: Improved access to currently synthesizable compounds
Funded projects:
Typical project outcomes:
-
Multiple development candidates generated: Case study B | Case study D
-
Multiple programs sold to/partnered to Pharma: Case study B | Case study A
-
Repeat projects with companies and collaborators: Case study A
BioBlocks chemists are often inventors on our clients' patents:
Recent Applications: